We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$7.91B
AUM Growth
-$1.76B
Cap. Flow
-$1.37B
Cap. Flow %
-17.29%
Top 10 Hldgs %
11.41%
Holding
2,902
New
788
Increased
705
Reduced
576
Closed
758

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$52.3M
2
EXC icon
Exelon
EXC
+$51.9M
3
LIN icon
Linde
LIN
+$48.3M
4
AMD icon
Advanced Micro Devices
AMD
+$41.5M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$39.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$251M
2
MSFT icon
Microsoft
MSFT
+$235M
3
AMZN icon
Amazon
AMZN
+$226M
4
CSGP icon
CoStar Group
CSGP
+$103M
5
AER icon
AerCap
AER
+$82.2M

Sector Composition

Rank Sector Weight
1 Technology 13.96%
2 Industrials 12.92%
3 Consumer Discretionary 9.79%
4 Financials 9.27%
5 Energy 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCB icon
926
Metropolitan Bank Holding Corp
MCB
$1.12B
$1.48M 0.02%
14,551
+8,645
+146% +$895K
OEC icon
927
Orion
OEC
$340M
$1.48M 0.02%
92,721
-10,191
-10% -$176K
JBI icon
928
Janus International
JBI
$696M
$1.48M 0.02%
164,355
+121,204
+281% +$1.23M
KDP icon
929
Keurig Dr Pepper
KDP
$44.2B
$1.47M 0.02%
38,886
-281,293
-88% -$10.7M
VIR icon
930
Vir Biotechnology
VIR
$1.68B
$1.47M 0.02%
+57,327
New +$1.7M
FBNC icon
931
First Bancorp
FBNC
$2.7B
$1.47M 0.02%
35,218
+12,657
+56% +$565K
COLM icon
932
Columbia Sportswear
COLM
$3.08B
$1.46M 0.02%
+16,162
New +$1.5M
OTTR icon
933
Otter Tail
OTTR
$3.87B
$1.46M 0.02%
23,404
+18,534
+381% +$1.16M
MYRG icon
934
MYR Group
MYRG
$4.75B
$1.46M 0.02%
15,543
+13,329
+602% +$1.27M
BEAM icon
935
Beam Therapeutics
BEAM
$2.93B
$1.46M 0.02%
25,473
+14,630
+135% +$960K
ICE icon
936
Intercontinental Exchange
ICE
$91.5B
$1.46M 0.02%
11,047
-27,394
-71% -$3.54M
Y
937
DELISTED
Alleghany Corp
Y
$1.46M 0.02%
1,722
+1,002
+139% +$694K
TNGX icon
938
Tango Therapeutics
TNGX
$4.13B
$1.46M 0.02%
192,325
+126,824
+194% +$1.1M
YEXT icon
939
Yext
YEXT
$656M
$1.46M 0.02%
211,542
+129,837
+159% +$991K
DSGX icon
940
Descartes Systems
DSGX
$6.72B
$1.46M 0.02%
+19,864
New +$1.43M
FCF icon
941
First Commonwealth Financial
FCF
$2.12B
$1.46M 0.02%
+96,007
New +$1.56M
SSYS icon
942
Stratasys
SSYS
$671M
$1.46M 0.02%
57,323
+13,480
+31% +$325K
XRN
943
Chiron Real Estate Inc
XRN
$494M
$1.45M 0.02%
17,749
-5,605
-24% -$459K
WHR icon
944
Whirlpool
WHR
$2.62B
$1.44M 0.02%
+8,351
New +$1.69M
OCDX
945
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$1.44M 0.02%
77,283
+29,663
+62% +$534K
UMPQ
946
DELISTED
Umpqua Holdings Corp
UMPQ
$1.44M 0.02%
76,371
+64,442
+540% +$1.32M
AGNC icon
947
AGNC Investment
AGNC
$13B
$1.44M 0.02%
109,599
+17,347
+19% +$243K
DK icon
948
Delek US
DK
$4.17B
$1.43M 0.02%
+67,566
New +$1.23M
BE icon
949
Bloom Energy
BE
$60B
$1.43M 0.02%
59,245
+49,465
+506% +$966K
UL icon
950
Unilever
UL
$141B
$1.42M 0.02%
27,738
+13,746
+98% +$765K

Similar funds

Michael Gelband's Q1 2022 Portfolio in Review

As of Q1 2022, Michael Gelband held 2,902 positions worth $7.91B, down 18% from $9.67B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Michael Gelband withdrew a net $1.37B in Q1 2022, closing 758 positions and reducing 576 holdings. Its most notable exit was CoStar Group, an estimated $103M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Michael Gelband opened a new position in Linde worth $49.9M.

  • Michael Gelband's largest Q1 2022 buy was Linde: 156,289 shares worth $49.9M.
  • Michael Gelband added most to ExxonMobil in Q1 2022, an estimated $52.3M increase.
  • Michael Gelband's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $251M.
  • Michael Gelband fully exited CoStar Group in Q1 2022, selling an estimated $103M.
  • Michael Gelband's ten largest holdings make up 11% of its $7.91B portfolio in Q1 2022.
  • Michael Gelband opened 788 new positions and closed 758 in Q1 2022.
  • Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.91B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.